Building Gene Therapies that Address Gain and Loss of Function Simultaneously

Guang Qu, chief operating officer and co-founder of NGGT, discusses the company’s dual-functional vectors that simultaneously remove harmful, mutated genes and replace them with normal, healthy genes to restore cellular function. https://globalgenes.org/raredaily/building-gene-therapies-that-address-gain-and-loss-of-function-simultaneously/